NewsMarkets

Health

LSD Returns to Clinical Trials After Decades of Prohibition

The psychedelic drug LSD is returning to clinical trials after moving from counterculture and secret CIA experiments back to psychiatric research.

1 publisher · 1 article · first seen 7 Oct 2026 · updated 2d ago

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 7 Oct 2026. Al Jazeera – Breaking News, World News and Video from Al Jazeera published first, on 7 October at 18:27 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. LSD – from counterculture to clinical trials Al Jazeera – Breaking News, World News and Video from Al Jazeera ·

In this story

  • CIA
Embed this story

Paste this into any web page to show the live odds, with a link back here.